SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Chugai Pharmaceutical Co., Ltd. (Japan) Announces Co-Development And Co-Marketing Agreement With Taisho Pharmaceutical For The Antiresorptive Bisphosphonate R484